Literature DB >> 15448215

High-dose intravenous azathioprine pulse treatment in refractory Wegener's granulomatosis.

P M Aries, B Hellmich, E Reinhold-Keller, W L Gross.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15448215     DOI： 10.1093/rheumatology/keh300

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  7 in total

Review 1.  [New therapeutic concepts for vasculitis and collagenosis].

Authors:  C Metzler; B Hellmich; A Gause
Journal:  Internist (Berl)       Date:  2005-12       Impact factor: 0.743

2.  Lack of efficacy of rituximab in Wegener's granulomatosis with refractory granulomatous manifestations.

Authors:  P M Aries; B Hellmich; J Voswinkel; M Both; B Nölle; K Holl-Ulrich; P Lamprecht; W L Gross
Journal:  Ann Rheum Dis       Date:  2005-11-03       Impact factor: 19.103

3.  Prolonged Remission of Psoriasis with Azathioprine Pulse Therapy.

Authors:  Ramji Gupta
Journal:  Indian J Dermatol       Date:  2015 Jul-Aug       Impact factor: 1.494

Review 4.  [Wegener's granulomatosis and microscopic polyangiitis].

Authors:  K de Groot; E Reinhold-Keller
Journal:  Z Rheumatol       Date:  2009-02       Impact factor: 1.372

Review 5.  Vasculitis treatment - new therapeutic approaches.

Authors:  Michael J Dillon
Journal:  Eur J Pediatr       Date:  2006-03-09       Impact factor: 3.183

6.  Rituximab in the treatment of refractory scleritis in patients with granulomatosis with polyangiitis (Wegener's).

Authors:  Claudia Recillas-Gispert; Juan Carlos Serna-Ojeda; Luis Felipe Flores-Suárez
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-10-27       Impact factor: 3.117

Review 7.  State of the art in the treatment of systemic vasculitides.

Authors:  Raashid Ahmed Luqmani
Journal:  Front Immunol       Date:  2014-10-13       Impact factor: 7.561
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.